AIN (Albany International Corp Class A) Stock Analysis - SEC Filings

Albany International Corp Class A (AIN) is a publicly traded Consumer Cyclical sector company. As of May 19, 2026, AIN trades at $60.43 with a market cap of $1.72B and a P/E ratio of -31.40. AIN moved -1.67% today. Year to date, AIN is +16.87%; over the trailing twelve months it is -11.48%. Its 52-week range spans $41.15 to $89.25. Analyst consensus is sell with an average price target of $55.00. Rallies surfaces AIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find AIN SEC filings?

Rallies organizes AIN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

AIN Key Metrics

Key financial metrics for AIN
MetricValue
Price$60.43
Market Cap$1.72B
P/E Ratio-31.40
EPS$-1.94
Dividend Yield0.28%
52-Week High$89.25
52-Week Low$41.15
Volume23.41K
Avg Volume0
Revenue (TTM)$1.18B
Net Income$-56.96M
Gross Margin20.62%

Latest AIN News

Recent AIN Insider Trades

  • Kleveland Gunnar bought 2.30K (~$96.70K) on Nov 17, 2025.
  • Kleveland Gunnar bought 1.75K (~$104.56K) on Aug 5, 2025.
  • Gaug Joseph M bought 500 (~$35.59K) on Nov 5, 2024.

AIN Analyst Consensus

2 analysts cover AIN: 0 strong buy, 0 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is sell. Average price target: $55.00.

Common questions about AIN

Where can I find AIN SEC filings?
Rallies organizes AIN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show AIN 10-K and 10-Q filings?
Rallies organizes AIN SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is AIN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AIN. It does not provide personalized investment advice.
AIN

AIN